-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Tracy Cooley
Tracy serves as the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues. She loves blogging and podcasting on all things biotech and believes in the great potential of the industry, looking for every opportunity to spread the message far and wide. Nearly everyone in her family is a golfer, and as such, she has what many people have called a “natural” swing. Sometimes she even hits the ball. Tracy just finished her ninth marathon, and has nearly mastered the skill of one-foot-in-front-of-the-other (usually, sometimes the laces get in the way). The joy of her life is her five-year-old daughter Josephine.
Latest Posts
Data Exclusivity Protects Innovators and Assures Investors
Biotechnology companies must have some certainty that they can protect their investment in the development of new breakthrough therapies for a substantial period of time. This protection helps companies secure much-needed venture capital funding, which is the lifeblood of the industry. A failure to include substantial data exclusivity would undermine incentives to invest in biomedical innovation and thus would slow progress in the development of breakthrough therapies to improve the health and lives of patients Read More >
World Diabetes Day: Get the Facts
Today, November 14, is World Diabetes Day and advocacy organizations around the world are focused on raising awareness for prevention and treatment options. How prevalent is diabetes? According to the 2011 National Diabetes Fact Sheet, there are more than 25 million children and adults in the U.S. with diabetes, which includes more than 18 million people who have been diagnosed and an estimated seven million people who have not yet been diagnosed. Nearly 80 million Read More >
A Start-Up Model Worthy of Consideration
Biotech LLCs are getting a lot of attention lately, and perhaps rightfully so. The Wall Street Journal’s Brian Gormley recently talked to Albert L. Sokol, a partner with Edwards Wildman Palmer, about the two venture-backed biotechs – Forma Therapeutics and Viamet Pharmaceuticals – that he helped convert to LLCs. In the WSJ article – Biotech Start-Ups See Benefits from Changing Structure, Lawyer Says – Sokol describes the benefits to start-ups and their venture investors, as Read More >
Amgen Hosts Science without Borders Students
This year, Amgen is hosting six Science without Borders undergraduate interns at its Thousand Oaks, California headquarters. The Science without Borders program is a Brazilian scholarship program that seeks to train 101,000 students and researchers in top universities worldwide in science, technology, engineering and math (STEM) fields by 2014. The Amgen internship program will provide students with a unique opportunity to experience the biotechnology industry. There was considerable interest in the programme with a high Read More >
Vertex Scientist Inspires Students with Aha! Moments
As a senior research scientist in protein biochemistry at Vertex, Bryan Vought, PhD, can measure his career as a series of ‘aha moments.’ “What is missing in the classroom is the thrill of these moments, when you know you have discovered something truly spectacular… these moments are the essence of exciting science,” said Dr. Vought. “Science in the classroom is akin to a foreign language course, they have to learn the language before they can Read More >
